New Study Segments the Life Science Market by Media Engagement Level
16 Novembre 2006 - 3:00PM
PR Newswire (US)
ARLINGTON, Va., Nov. 16 /PRNewswire/ -- BioInformatics, LLC
announced today the availability of a new report "Marketing to Life
Scientists 2006: Capitalizing on Media Engagement." As a basis for
the report, 1300 scientists worldwide were surveyed to determine
their media preferences and preferred suppliers. The resulting
report is an indispensable guidebook for life science marketing.
"Marketing to Life Scientists 2006" provides insights into the
media preferences of life scientists and also identifies suppliers
considered to be best-in-class in each of six major marketing media
-- print catalogs, Web sites, direct mail, sales representatives,
print advertising, and scientific meetings and exhibits. Most
importantly, this report identifies a segment of life scientists
who are Highly Engaged with the marketing communication of their
suppliers and provides strategic insight into marketing to this
potentially lucrative group. Life scientists who are Highly Engaged
differ significantly from less engaged scientists in their media
preferences and response to marketing communications. Understanding
the preferences of Highly Engaged scientists will allow suppliers
to tailor their marketing messages to this segment and thereby
maximize the effectiveness of their campaigns. Because Highly
Engaged scientists are more likely to obtain product information
from most available sources, marketing to the Highly Engaged
scientist can enable suppliers to build a loyal core audience who
may then become brand champions influencing the purchases of less
engaged colleagues. "Life science marketing professionals are
always looking for new ways to understand their customer and, more
importantly, ensure that their message is well-received and
effective. The information provided in this report supplies
critical insights into new ways to understand the customer and
their needs so that the supplier can perfect their media
selection," stated Bill Kelly, President of BioInformatics. The
scientists surveyed also ranked the effectiveness of their
suppliers' marketing programs in terms of "best" Web site, print
catalog, exhibits, print advertising and sales force. While
hundreds of companies were mentioned, market leaders such as
Bio-Rad Laboratories (AMEX:BIO), BD Biosciences (NYSE:BDX), Fisher
Scientific (NYSE:FSH), Invitrogen (NASDAQ:IVGN), Sigma- Aldrich
(NASDAQ:SIAL), and New England Biolabs all received exceptionally
high rankings in multiple categories. Based on an additional
analysis of media engagement of the top thirty life science
suppliers, BioInformatics identified Agilent Technologies (NYSE:A)
and Roche Applied Sciences as being particularly adept at
communicating with Highly Engaged Scientists. Behind the leaders,
Clontech Laboratories (a Takara Bio company), New England Biolabs
and GE Healthcare, a division of General Electric (NYSE:GE), were
also found to be especially successful in creating marketing
material that is thoroughly reviewed by an above average number of
Highly Engaged scientists. For a complimentary Executive Summary of
this report, please visit http://www.gene2drug.com/reports ABOUT
BIOINFORMATICS, LLC BioInformatics, LLC is a market research and
consulting firm located in Arlington, Virginia. BioInformatics
supports marketing, sales and R&D executives in the life
science, medical device and pharmaceutical industries through
published research reports, custom research and consulting.
BioInformatics sponsors the world's largest market research panel
of scientific customers -- The Science Advisory Board
(http://www.scienceboard.net/) -- which consists of more than
31,000 scientists, physicians and other life science and medical
professionals from 62 countries who participate in surveys that
address emerging technologies, test customer reactions to new
product concepts, measure brand awareness and assess advertising
effectiveness. For more information, please contact: Amanda
Donathen BioInformatics, LLC 2111 Wilson Blvd., Suite 250
Arlington, VA 22201 703.778.3080 x14 (phone) 703.778.3081 (fax)
http://www.gene2drug.com/ DATASOURCE: BioInformatics, LLC CONTACT:
Amanda Donathen of BioInformatics, LLC, +1-703-778-3080 x14,
+1-703-778-3081 fax, or Web site: http://www.gene2drug.com/
Copyright
Fisher Scientific (NYSE:FSH)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Fisher Scientific (NYSE:FSH)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024